Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Teva
Fuji
Chinese Patent Office
Citi
Farmers Insurance
QuintilesIMS
US Army
McKesson

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021171

« Back to Dashboard

NDA 021171 describes DEMEROL, which is a drug marketed by Hospira and Us Pharm Holdings and is included in two NDAs. It is available from four suppliers. Additional details are available on the DEMEROL profile page.

The generic ingredient in DEMEROL is meperidine hydrochloride. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.
Summary for 021171
Tradename:DEMEROL
Applicant:Hospira
Ingredient:meperidine hydrochloride
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details
Pharmacology for NDA: 021171
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for 021171
Suppliers and Packaging for NDA: 021171
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 021171 NDA Hospira, Inc. 0409-1176 N 0409-1176-30
DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 021171 NDA Hospira, Inc. 0409-1178 N 0409-1178-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength25MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength75MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Fish and Richardson
McKinsey
McKesson
Citi
Queensland Health
Chinese Patent Office
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.